Chongqing Genrix Biopharmaceutical Co., Ltd. (SHA:688443)
China
· Delayed Price · Currency is CNY 21.43
-0.74 (-3.34%)
At close: Jun 26, 2026
Chongqing Genrix Biopharmaceutical Employees
Chongqing Genrix Biopharmaceutical had 793 employees as of June 30, 2025. The number of employees increased by 50 or 6.73% since the number was reported on December 31, 2024.
Employees
793
Change
50
Growth
6.73%
Revenue / Employee
282.34K CNY
Profits / Employee
-573.51K CNY
Market Cap
7.86B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 793 | 50 | 6.73% |
| Dec 31, 2024 | 743 | 196 | 35.83% |
| Dec 31, 2023 | 547 | 155 | 39.54% |
| Dec 31, 2022 | 392 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Liaoning Chengda Biotechnology | 1,781 |
| Innovita Biological Technology | 571 |
| Nanjing Vazyme Biotech | 3,002 |
| Vcanbio Cell & Gene Engineering Corp., | 1,935 |
| Aurisco Pharmaceutical | 2,026 |
| Jiangsu Sinopep-Allsino Biopharmaceutical | 2,360 |
| Sino Biological,Inc. | 1,069 |
| Pacific Shuanglin Bio-pharmacy | 2,755 |